Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HAS Healthcare Advanced Synthesis provides contract development and manufacturing services for APIs, HPAPIs, anticancer compounds and advanced intermediates. The company operates cGMP-certified facilities inspected by FDA and SwissMedic. In March 2025 it announced the acquisition of Cerbios‑Pharma SA to expand its capabilities into biologics and antibody-drug conjugates. It serves global pharma/biotech clients with a focus on oncology and rare diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HAS Healthcare Advanced Synthesis.